Syphilitic interstitial keratitis treated with topical tacrolimus

Jacob Martin1, Laura Kopplin2, Deborah Costakos1

  • 1Medical College of Wisconsin, 925 N 87th St, Milwaukee, WI, 53226, USA.

Insights

Topical tacrolimus offers a new treatment for syphilitic interstitial keratitis in children. This approach is effective for patients experiencing steroid-induced high intraocular pressure, preventing disease recurrence.

Area of Science:

  • Ophthalmology
  • Infectious Diseases
  • Pediatrics

Background:

  • Syphilitic interstitial keratitis (SIK) is an inflammatory eye condition often associated with congenital syphilis.
  • Standard treatment involves topical steroids, which can lead to significant side effects like elevated intraocular pressure (IOP).

Observation:

  • A pediatric patient with congenital syphilis presented with bilateral SIK.
  • Initial management with topical steroids resulted in steroid-induced ocular hypertension and recurrent keratitis.
  • Topical tacrolimus was administered following a recurrence in the right eye.

Findings:

  • The patient achieved sustained remission of SIK with topical tacrolimus.
  • Normal intraocular pressure was maintained throughout the treatment period.
  • The patient remained recurrence-free for nearly three years.

Implications:

  • Topical tacrolimus is a promising alternative for managing SIK, especially in pediatric cases.
  • This treatment is particularly valuable for patients intolerant to steroids due to elevated IOP.
  • Tacrolimus offers a steroid-sparing option for chronic or recurrent SIK.
Abstract